INSIGHTIA Journal of Research and Innovation
Peer-reviewed | Support Open Access | Applied Science
About Insightia
Insightia is a multidisciplinary, open-access journal dedicated to accelerating innovation in pharmaceutical and applied sciences. We publish original research, reviews, short communications and case reports demonstrating methodological rigor, ethical conduct and practical relevance — from drug discovery and formulation to biomedical engineering, materials science, environmental applications and data-driven solutions.
⏱️ Publication Timeline
📩 Submission to First Decision
4 Days (Median)
🔍 Submission to Decision After Peer Review
28 Days
✅ Submission to Acceptance
4 Days
🌐 Acceptance to Online Publication
15 Days
Aims & Scope
Insightia welcomes high-quality manuscripts that advance knowledge or application in areas including (but not limited to):
Pharmaceutical Sciences
Pharmaceutics, pharmacology, pharmacognosy, clinical pharmacy and drug delivery systems.
Biomedical & Life Sciences
Biotechnology, microbiology, bioinformatics, systems biology and translational research.
Chemical & Materials Science
Medicinal chemistry, biomaterials, nanomedicine and analytical techniques.
Engineering & Data Science
Biomedical engineering, diagnostics, AI in drug discovery and manufacturing technologies.
Latest Issue — Highlights
All Volumes
For Authors — Quick Summary
Submission
Online via our submission portal
Manuscript Types
Original research, reviews, brief communications, case studies.
Formatting
Abstract 150–250 words; 3–6 keywords; references in Vancouver or APA style.
Peer Review
Double-blind review, typical first decision in 4 days.
Call for Papers
Current special issue: “AI & Sustainable Health” — submissions accepted until 31 July 2026.